These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31754993)

  • 1. Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis.
    Gu P; Patel D; Lakhoo K; Ko J; Liu X; Chang B; Pan D; Lentz G; Sonesen M; Estiandan R; Lin E; Pimentel M; Rezaie A
    Dig Dis Sci; 2020 Aug; 65(8):2388-2396. PubMed ID: 31754993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis.
    Gandhi A; Shah A; Jones MP; Koloski N; Talley NJ; Morrison M; Holtmann G
    Gut Microbes; 2021; 13(1):1933313. PubMed ID: 34190027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting a Response to Antibiotics in Patients with the Irritable Bowel Syndrome.
    Kasir R; Zakko S; Zakko P; Adler M; Lee A; Dhingra S; Guttermuth C
    Dig Dis Sci; 2016 Mar; 61(3):846-51. PubMed ID: 26362282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.
    Zhao J; Zheng X; Chu H; Zhao J; Cong Y; Fried M; Fox M; Dai N
    Neurogastroenterol Motil; 2014 Jun; 26(6):794-802. PubMed ID: 24641100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy.
    Ghoshal UC; Shukla R; Ghoshal U
    Gut Liver; 2017 Mar; 11(2):196-208. PubMed ID: 28274108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease.
    Shah A; Morrison M; Burger D; Martin N; Rich J; Jones M; Koloski N; Walker MM; Talley NJ; Holtmann GJ
    Aliment Pharmacol Ther; 2019 Mar; 49(6):624-635. PubMed ID: 30735254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis on small intestinal bacterial overgrowth in patients with different subtypes of irritable bowel syndrome.
    Ghoshal UC; Nehra A; Mathur A; Rai S
    J Gastroenterol Hepatol; 2020 Jun; 35(6):922-931. PubMed ID: 31750966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
    Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome.
    Tuteja AK; Talley NJ; Stoddard GJ; Verne GN
    Dig Dis Sci; 2019 Mar; 64(3):838-845. PubMed ID: 30370492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.
    Yang M; Zhang L; Hong G; Li Y; Li G; Qian W; Xiong H; Bai T; Song J; Hou X
    J Gastroenterol Hepatol; 2020 May; 35(5):795-805. PubMed ID: 31674052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: an observation on non-absorbable antibiotics.
    Esposito I; de Leone A; Di Gregorio G; Giaquinto S; de Magistris L; Ferrieri A; Riegler G
    World J Gastroenterol; 2007 Dec; 13(45):6016-21. PubMed ID: 18023092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity Is Inversely Related to Hydrogen-Producing Small Intestinal Bacterial Overgrowth in Non-Constipation Irritable Bowel Syndrome.
    Jung SE; Joo NS; Han KS; Kim KN
    J Korean Med Sci; 2017 Jun; 32(6):948-953. PubMed ID: 28480652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The dietary features of diarrhea predominant irritable bowel syndrome patients with small intestinal bowel overgrowth].
    Wei H; Liu ZJ; Wang K; Zheng W; Duan LP
    Zhonghua Nei Ke Za Zhi; 2017 Aug; 56(8):567-571. PubMed ID: 28789488
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical value of radionuclide small intestine transit time measurement combined with lactulose hydrogen breath test for the diagnosis of bacterial overgrowth in irritable bowel syndrome.
    Ning Y; Lou C; Huang Z; Chen D; Huang H; Chen L; Zhang B; Dai N; Zhao J; Zhen X
    Hell J Nucl Med; 2016; 19(2):124-9. PubMed ID: 27331205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small intestine bacterial overgrowth in patients with irritable bowel syndrome.
    Carrara M; Desideri S; Azzurro M; Bulighin GM; Di Piramo D; Lomonaco L; Adamo S
    Eur Rev Med Pharmacol Sci; 2008; 12(3):197-202. PubMed ID: 18700692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome.
    Sundin J; Aziz I; Nordlander S; Polster A; Hu YOO; Hugerth LW; Pennhag AAL; Engstrand L; Törnblom H; Simrén M; Öhman L
    Sci Rep; 2020 Jan; 10(1):593. PubMed ID: 31953505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small intestinal bacterial overgrowth is associated to symptoms in irritable bowel syndrome. Evidence from a multicentre study in Romania.
    Moraru IG; Moraru AG; Andrei M; Iordache T; Drug V; Diculescu M; Portincasa P; Dumitrascu DL
    Rom J Intern Med; 2014; 52(3):143-50. PubMed ID: 25509557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial.
    Ghoshal UC; Srivastava D; Misra A; Ghoshal U
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):281-9. PubMed ID: 26731696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis.
    Halpin SJ; Ford AC
    Am J Gastroenterol; 2012 Oct; 107(10):1474-82. PubMed ID: 22929759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
    Shah A; Talley NJ; Jones M; Kendall BJ; Koloski N; Walker MM; Morrison M; Holtmann GJ
    Am J Gastroenterol; 2020 Feb; 115(2):190-201. PubMed ID: 31913194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.